ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

LGND Ligand Pharmaceuticals Incorporated

70,57
0,20 (0,28%)
27 Avr 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 88 152
Prix Achat 68,02
Prix Vente 74,97
Actualités -
Maximum Haut 72,085

Bas
49,24

Sur 52 semaines

Haut
94,57

Minimum Bas 70,21
Nom Action Symbole Action Marché Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,20 0,28% 70,57 00:36:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
70,59 70,21 72,085 70,57 70,37
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
2 631 88 152 US$ 71,09 US$ 6 267 074 - 49,24 - 94,57
Dernière Transaction Type Quantités échangées Prix transaction Devise
22:13:44 6 US$ 70,57 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
1,25B 17,71M - 131,31M 52,15M 2,95 23,97
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Ligand Pharmaceuticals

Date Heure Source Titre
07/3/202419:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
01/3/202422:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
01/3/202400:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]
29/2/202400:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
28/2/202423:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
27/2/202413:24Edgar (US Regulatory)Form 8-K - Current report

Forum Action Ligand Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Ligand Pharmaceuticals Incorporated

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine71,9372,9867,7270,19156 972-1,36-1,89%
1 mois73,3581,7367,7276,19162 176-2,78-3,79%
3 mois73,3594,5767,7275,81181 356-2,78-3,79%
6 mois50,4494,5749,2471,19143 21020,1339,91%
1 an75,8994,5749,2469,92121 006-5,32-7,01%
3 ans146,12169,9849,2495,19144 498-75,55-51,70%
5 ans124,46219,7549,24106,02240 266-53,89-43,30%

Dernières Valeurs Consultées

Delayed Upgrade Clock